Search the Newsreel

Saturn V Capital shows sub-5% Monopar Therapeutics (MNPR) stake in 13G/A

Monolithic Power Systems (MPWR) Stock Could Be Above Fair Value Following Investor Alert

Monopar Therapeutics (NASDAQ:MNPR) Issues Quarterly Earnings Results, Misses Expectations By $0.13 EPS

Monopar Therapeutics (NASDAQ:MNPR) reported a quarterly EPS of ($0.79), missing analysts' consensus estimate of ($0.66) by $0.13. Despite the earnings miss, the stock is trading near its 52-week high, and analysts maintain a "Buy" rating with a consensus price target of $112.08. Institutional investors …

Should Investors Buy MPWR as AI Growth Meets a Premium Valuation?

Monolithic Power Systems, Inc. MPWR is entering a higher earnings base as artificial intelligence (AI) and server demand lifts its data-center power business. Second-quarter 2026 revenues rose 47.6% year over year, while non-GAAP earnings increased 54.4% to $6.50 per share. The question for investors …

MPWR Raises 2026 Enterprise Data Growth Floor as AI Demand Surges

Monolithic Power Systems, Inc. MPWR raised its 2026 Enterprise Data growth floor to 130% from 85% after a sharp acceleration in artificial intelligence (AI) and server demand. Second-quarter Enterprise Data revenue more than doubled year over year and accounted for 38.8% of total revenues. …

Adage Capital discloses 4.76% Monopar Therapeutics (MNPR) stake including warrants

Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, has reported a beneficial ownership of 4.76% in Monopar Therapeutics Inc. (MNPR). This stake includes 324,195 shares of common stock, with 115,000 shares being issuable upon the exercise of warrants. The ownership represents …

Monopar Q2 Net Loss Widens; Rolling NDA Submission For ALXN1840 In Wilson Disease Underway

(RTTNews) - Monopar Therapeutics Inc. (MNPR), a clinical-stage biopharmaceutical company, reported financial results for the second quarter of 2026, reflecting a wider net loss, and provided an update on its investigational pipeline. Monopar Therapeutics' lead investigational candidate ALXN1840 (tiomolibdate choline, TMC) is in development …

Monopar Therapeutics reports Q2 2026: $5.3M net loss, $134.3M cash on hand

Monopar Therapeutics reported a net loss of $5.3 million for Q2 2026 and held $134.3 million in cash, cash equivalents, and investments. The company expects these funds to support operations through at least December 31, 2027, as it advances an NDA rolling submission for …

Monopar Therapeutics (MNPR) deepens R&D spend but retains $134M cash runway

Monopar Therapeutics (MNPR) reported a net loss of $9.21 million for the first half of 2026, an increase from $5.08 million a year prior, primarily due to higher research and development (R&D) spending on its ALXN1840 Wilson disease program and radiopharmaceutical pipeline. Despite the …

Monolithic Power Systems, Inc. $MPWR Shares Bought by Handelsbanken Fonder AB

Monolithic Power Systems, Inc. $MPWR Stake Reduced by NewEdge Advisors LLC

Monolithic Power Systems (MPWR) Heads To FMS 2026 With AI Storage Focus

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Monolithic Power Systems (NasdaqGS:MPWR) is scheduled to present at the Future of Memory and Storage 2026 conference. The FMS 2026 event focuses on …

Why Monolithic (MPWR) Might be Well Poised for a Surge

Monolithic Power (MPWR) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company. The upward trend …

Monolithic Power Systems, Inc. $MPWR Shares Acquired by Czech National Bank

The Czech National Bank increased its stake in Monolithic Power Systems (NASDAQ:MPWR) by 5.4% in the second quarter, bringing its total holdings to 13,984 shares valued at $19.33 million. Other institutional investors and hedge funds also adjusted their positions in the semiconductor company. Analysts …

Monopar Therapeutics (NASDAQ:MNPR) Upgraded at Wall Street Zen

Monopar Therapeutics (NASDAQ:MNPR) has been upgraded from a "sell" to a "hold" rating by Wall Street Zen, though the broader analyst consensus remains a "Buy" with an average price target of $112.08. The company recently reported better-than-expected quarterly EPS of negative $0.46 and has …

Monolithic Power Systems (NASDAQ:MPWR) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen has upgraded Monolithic Power Systems (NASDAQ:MPWR) from a "hold" to a "buy" rating, contributing to a consensus "Moderate Buy" rating for the stock with an average price target of $1,705.82. This upgrade follows the company's strong quarterly performance, where it exceeded …

Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview

Monopar Therapeutics Inc. is projected to report a loss of 62 cents per share, according to this earnings preview. The article indicates that this information comes from Reuters via Refinitiv and is accessible through TradingView's news platform.

Cómo están reaccionando los inversores ante los sólidos resultados del segundo trimestre de Monolithic Power Systems (MPWR), sus previsiones al alza y su mayor programa de recompra de acciones

Monolithic Power Systems Stock And 2 AI Infrastructure Picks With Strong Earnings Growth

How Investors Are Reacting To Monolithic Power Systems (MPWR) Strong Q2 Results, Higher Guidance, And Bigger Buyback

Monolithic Power Systems, Inc (MPWR) Investor Alert: Possible False Statements After 30% Stock Drop

Schubert Jonckheer & Kolbe is investigating Monolithic Power Systems, Inc. (MPWR) for alleged false statements regarding the quality and performance of its power management integrated circuits and its relationship with Nvidia. A U.S. District Judge ruled that key claims in a securities fraud lawsuit …

Buy MPWR and MCHP With Solid Short-Term Price and Long-Term EPS Upside

The artificial intelligence (AI)-driven marvelous bull story of U.S. stock markets for the past three and a half years is showing no sign of abatement. AI infrastructure stocks are flourishing on Wall Street with more vigor. Here, we have identified Monolithic Power Systems Inc. …

Monolithic Power Systems, Inc. (NASDAQ:MPWR) Given Average Rating of "Moderate Buy" by Brokerages

Monolithic Power Systems (NASDAQ:MPWR) has received a "Moderate Buy" rating from brokerages, with an average 12-month price target of $1,705.82. This positive outlook follows the company's strong quarterly results, which surpassed EPS and revenue expectations. Despite significant insider selling totaling $40.5 million over the …

Monolithic Power Systems (MPWR) Posts Strong Q2 Growth, Is It Fully Priced?

Robert Dean (MPWR) files notice to sell Monolithic Power common stock

Robert Dean has filed a Form 144 notice indicating his intent to sell 105 shares of Monolithic Power Systems (MPWR) common stock through Morgan Stanley Smith Barney LLC on or after August 5, 2026. The filing also reports previous sales of MPWR common stock, …

Monolithic Power Systems (NASDAQ:MPWR) EVP Sells 30 Shares of Stock

Monolithic Power Systems' EVP Maurice Sciammas recently sold 30 shares of the company's stock for approximately $40,318 under a pre-arranged Rule 10b5-1 plan, reducing his total holdings to 1,119 shares. This insider sale follows strong quarterly results where the company reported $6.50 EPS, beating …

[10-Q] MONOLITHIC POWER SYSTEMS INC Quarterly Earnings Report

Monolithic Power Systems Inc. (MPWR) filed its quarterly earnings report (Form 10-Q) for the period ending June 30, 2026. The report highlights a new $500 million authorization for common-stock repurchases and discusses the potential issuance of approximately 697,000 shares through performance-based units by July …

Monolithic Power Systems, Inc. $MPWR Shares Sold by Carderock Capital Management Inc.

Carderock Capital Management Inc. reduced its stake in Monolithic Power Systems (MPWR) by 11.7% in the second quarter, selling 1,364 shares. Despite this, other institutional investors have increased their positions, and Monolithic Power Systems reported strong quarterly earnings, beating analyst expectations. While Wall Street …

Monopar Therapeutics stock approaches $125.77 resistance as bullish momentum drives gains

Previsiones: Los analistas consideran que las perspectivas empresariales de Monolithic Power Systems, Inc. (NASDAQ:MPWR) han mejorado drásticamente

Pacer Advisors Inc. Trims Stake in Monolithic Power Systems, Inc. $MPWR

Pacer Advisors Inc. reduced its stake in Monolithic Power Systems (NASDAQ:MPWR) by 23.4% in the first quarter, now holding 38,807 shares valued at $42.4 million. Despite the institutional selling, analysts maintain a "Moderate Buy" rating with an average price target of $1,705.82, following the …

Monolithic Power Systems (MPWR) Q2 2026 Earnings Call Transcript

Monolithic Power Systems (MPWR) reported record Q2 2026 revenue of $981 million, a 48% year-over-year increase, driven primarily by strong demand in enterprise data and communications. The company is transitioning into a full-solution provider, expanding manufacturing capacity and diversifying its supply chain, while seeing …

Monopar Therapeutics (MNPR) Projected to Post Earnings on Tuesday

Forecast: Analysts Think Monolithic Power Systems, Inc.'s (NASDAQ:MPWR) Business Prospects Have Improved Drastically

Monolithic Power (MPWR) Crossed Above the 20-Day Moving Average: What That Means for Investors

Monolithic Power (MPWR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, MPWR crossed above the 20-day moving average, suggesting a short-term bullish trend. A well-liked tool among traders, the 20-day simple moving …

Sapient Capital LLC Lowers Stock Holdings in Monolithic Power Systems, Inc. $MPWR

Sapient Capital LLC significantly reduced its stake in Monolithic Power Systems (NASDAQ:MPWR) by 37.1% in the first quarter, selling 13,194 shares and retaining 22,370 shares valued at approximately $24.5 million. Despite insider selling, institutional investors collectively own 93.46% of the company, and analysts maintain …